Login / Signup

Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients.

Takashi HiramaLianne G SingerSarah K BrodeTheodore K MarrasShahid Husain
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Anti-mycobacterial therapy may relieve pulmonary symptoms and reduce microbial load among individuals with post-transplant NTM-PD.
Keyphrases
  • pulmonary hypertension
  • mycobacterium tuberculosis
  • microbial community
  • stem cells
  • depressive symptoms
  • mesenchymal stem cells
  • physical activity
  • bone marrow